Biotechnology

NOVELYEAST-SUPERIOR YEAST AS A TARGET AND A TOOL

NovelYeast is an R&D company with world-leading expertise in the design and development of superior industrial yeast strains. Our superior yeast strains for bioethanol and isobutanol production support the transition to a more sustainable bio-based economy in the sectors of automobile and aviation transport. Superior yeast strains for production of bio-based chemicals support reduction of […]

NOVELYEAST-SUPERIOR YEAST AS A TARGET AND A TOOL Read More »

GENO.ME, A REAL-WORLD APPROACH TO BETTER CLINICAL RESEARCH OUTCOMES

Geno.Me is a biotechnology company that was born from the idea of empowering people to take greater ownership of their health data, because it is a valuable and necessary asset to advance medical research. With a focus on creating better ways to treat populations that have diseases with a genetic predisposition, the organization allows people

GENO.ME, A REAL-WORLD APPROACH TO BETTER CLINICAL RESEARCH OUTCOMES Read More »

IMUNOVA-EXPLORE THE MOST ADVANCED TECHNIQUES IN ANIMAL RESEARCH, ALONG WITH BIOTECHNOLOGICAL SOLUTIONS FOR PRODUCT DEVELOPMENT AND DIAGNOSTICS.

IMUNOVA-EXPLORE THE MOST ADVANCED TECHNIQUES IN ANIMAL RESEARCH, ALONG WITH BIOTECHNOLOGICAL SOLUTIONS FOR PRODUCT DEVELOPMENT AND DIAGNOSTICS. Imunova: Pioneering Breakthroughs in Biotechnology for Animal Health Curitiba (Brazil)-based biotechnology firm, Imunova, is at the forefront of innovation in animal health, dedicated to testing and developing cutting edge products for the veterinary industry. Established in 2011 as

IMUNOVA-EXPLORE THE MOST ADVANCED TECHNIQUES IN ANIMAL RESEARCH, ALONG WITH BIOTECHNOLOGICAL SOLUTIONS FOR PRODUCT DEVELOPMENT AND DIAGNOSTICS. Read More »

SYRIDEX-BIOPHARMA INVESTMENT FIRM SYRIDEX BIO ADDRESSES HEALTH EQUITY BY FUNDING R&D OF THERAPIES DISPROPORTIONATELY AFFECTING UNDERSERVED POPULATIONS

BIOPHARMA INVESTMENT FIRM SYRIDEX BIO ADDRESSES HEALTH EQUITY BY FUNDING R&D OF THERAPIES DISPROPORTIONATELY AFFECTING UNDERSERVED POPULATIONS. Princeton-based Syridex Bio is a biopharma investment firm that makes early-stage, venture creation investments in innovative treatments that can bring transformative changes to diseases disproportionately affecting underserved communities. It is uniquely focused on double bottom-line returns, delivering compelling

SYRIDEX-BIOPHARMA INVESTMENT FIRM SYRIDEX BIO ADDRESSES HEALTH EQUITY BY FUNDING R&D OF THERAPIES DISPROPORTIONATELY AFFECTING UNDERSERVED POPULATIONS Read More »

TransBIOTech-CCTT EN BIOTECHNOLOGIES

TransBIOTech, centre collégial de transfert en Biotechnologie, a été fondé en 1999 à la demande du Cégep de Lévis et s’appuie sur ses programmes techniques en biotechnologies et chimie analytique. Organisme à but non lucratif, TransBIOTech se spécialise en démonstrations d’efficacité et d’innocuité sur des composés actifs naturels destinés aux produits du mieuxêtre ou encore

TransBIOTech-CCTT EN BIOTECHNOLOGIES Read More »

QUEBEC CENTER FOR INNOVATION IN BIOTECHNOLOGY (CQIB)-THE QBIC, AT THE HEART OF THE LIFE SCIENCES ENTREPRENEURIAL ECOSYSTEM

Readers of this publication know that Quebec is an incredibly fertile breeding ground for innovation. One of the reasons we generate so much innovation in Quebec is that we have mobilizing organizations in place that catalyze our expertise and knowledge. Among these organizations, the Québec Biotechnology Innovation Centre (QBIC) stands out. Created in 1996, QBIC

QUEBEC CENTER FOR INNOVATION IN BIOTECHNOLOGY (CQIB)-THE QBIC, AT THE HEART OF THE LIFE SCIENCES ENTREPRENEURIAL ECOSYSTEM Read More »

CENTRE QUÉBÉCOIS D’INNOVATION EN BIOTECHNOLOGIE (CQIB)-LE CQIB, AU CŒUR DE L’ÉCOSYSTÈME ENTREPRENEURIAL EN SCIENCES DE LA VIE

Les lecteurs de cette publication sont bien placés pour le savoir : le Québec est un terreau incroyablement fertile pour l’innovation. Si on génère autant d’innovations en sol québécois, c’est notamment parce que nous avons en place des organisations mobilisatrice qui catalyse notre expertise et notre savoir. Parmi ces organisations, le Centre québécois d’innovation en

CENTRE QUÉBÉCOIS D’INNOVATION EN BIOTECHNOLOGIE (CQIB)-LE CQIB, AU CŒUR DE L’ÉCOSYSTÈME ENTREPRENEURIAL EN SCIENCES DE LA VIE Read More »

MODERN MEADOW-A PROTEIN DESIGN AND APPLICATION POWERHOUSE USING SYNBIO TO POWER NEXT-GEN SUSTAINABLE MATERIALS

A LEADER IN BIOFABRICATIONModern Meadow, headquartered in Nutley, NJ, is a sustainable bio-design technology company that uses nature-inspired proteins to develop solutions that reduce our reliance on petrochemical and animal-derived inputs. The company creates solutions that make sustainable high-performance materials possible. Modern Meadow is a protein design and application powerhouse, creating next-generation materials using synthetic

MODERN MEADOW-A PROTEIN DESIGN AND APPLICATION POWERHOUSE USING SYNBIO TO POWER NEXT-GEN SUSTAINABLE MATERIALS Read More »

CÉPROCQ- ince 2000, CÉPROCQ has positioned itself as a technological showcase on a pilot scale for extraction and separation processes in the fields of bio-industrial technologies and environmental technologies by promoting green processes commonly called clean processes or eco-processes: supercritical fluids, development of green solvents, minimization and treatment of waste and industrial discharges, etc

Thus, the CÉPROCQ, early on, based its strategic priorities on green chemistry and sustainable development, which have now become essential to the growth of the industry. The CÉPROCQ is one of the few centers in Quebec, or even in Canada, to offer a research infrastructure on a pilot scale, thereby filling a gap in the

CÉPROCQ- ince 2000, CÉPROCQ has positioned itself as a technological showcase on a pilot scale for extraction and separation processes in the fields of bio-industrial technologies and environmental technologies by promoting green processes commonly called clean processes or eco-processes: supercritical fluids, development of green solvents, minimization and treatment of waste and industrial discharges, etc Read More »

CÉPROCQ-Dès 2000, le CÉPROCQ s’est positionné comme une vitrine technologique à l’échelle pilote des procédésd’extraction et de séparation dans les domaines des technologies bioindustrielles et des technologies environnementales en faisant la promotion des procédés verts appelés communément procédés propresou écoprocédés: fluides supercritiques, développement de solvants verts, minimisation et traitement desdéchets et des rejets industriels, etc

Ainsi, le CÉPROCQ a, de façon précoce, fait asseoir ses priorités stratégiques sur la chimie verte et le développement durable devenus aujourd’hui incontournables dans la croissance de l’industrie. Le CÉPROCQ est l’un des rares centres au Québec, voire au Canada, à offrir une infrastructure de recherche à l’échelle pilote venant, ainsi, combler une lacune dans

CÉPROCQ-Dès 2000, le CÉPROCQ s’est positionné comme une vitrine technologique à l’échelle pilote des procédésd’extraction et de séparation dans les domaines des technologies bioindustrielles et des technologies environnementales en faisant la promotion des procédés verts appelés communément procédés propresou écoprocédés: fluides supercritiques, développement de solvants verts, minimisation et traitement desdéchets et des rejets industriels, etc Read More »

L’I2E3 -50 ans d’innovations biosourcées

L’Institut d’Innovations en Écomatériaux, Écoproduits et Écoénergies (I2E3) se veut une entité pluridisciplinaire participant à l’avancement de l’économie biosourcée dans une perspective d’économie verte, circulaire et régionale. L’I2E3 est l’évolution stratégique d’un centre de recherche en pâtes et papiers ayant démarré ses activités à l’Université du Québec à Trois-Rivières en 1972 et dont les connaissances

L’I2E3 -50 ans d’innovations biosourcées Read More »

BIOQuébec-Your Gateway to the Life Sciences Sector

BIOQuébec-Votre porte d’entrée du secteur des sciences de la vie

Grâce à ses liens avec les organisations issues de tous les maillons de la chaîne de valeur en sciences de la vie, BIOQuébec vous aide à explorer de nouvelles opportunités d’affaires et à entrer en relation avec les personnes-clés de l’écosystème québécois. Depuis 1991, l’association des biotechnologies et des sciences de la vie favorise la

BIOQuébec-Votre porte d’entrée du secteur des sciences de la vie Read More »

CRBM- Une organisation de haute technologie en biotechnologies marines!

CRBM-A high-tech organization in marine biotechnologies!

The CRBM is recognized for its unique positioning as a transfer research organization in marine biotechnologies. With the investment of the Government of Quebec and Canada, completed by industrial contributions, the CRBM team leads projects framed by a solid scientific program oriented towards two research axes: health and well-being and the environment. The CRBM’s mission

CRBM-A high-tech organization in marine biotechnologies! Read More »

CRBM- Une organisation de haute technologie en biotechnologies marines!

CRBM- Une organisation de haute technologie en biotechnologies marines!

La mission du CRBM est de supporter et de contribuer à la croissance de la filière des biotechnologies marines par des activités de recherche et développement scientifique et de transfert industriel, notamment pour le secteur des sciences de la vie.   Le CRBM est reconnu pour son positionnement unique comme centre d’innovation industrielle en biotechnologies

CRBM- Une organisation de haute technologie en biotechnologies marines! Read More »

MINIONE- INTRODUCED IN 2014

MINIONE- INTRODUCED IN 2014, MINIONE® SYSTEMS IS A BRAND OF EDUCATIONAL LIFE SCIENCE PRODUCTS DEVELOPED BY THE COMPANY EMBI TEC®, WHICH HAS FOR YEARS MANUFACTURED BIOTECH EQUIPMENT AND REAGENTS USED BY TOP RESEARCH FACILITIES ALL OVER THE WORLD

When its founders, Richard Chan and Winston Walker, learned that educators were purchasing their research-grade equipment to help students get hands-on experience with electrophoresis in their classrooms, they sought to develop a teacher and student-friendly electrophoresis system that was safe, compact, fast, and affordable, making it possible to complete inquiry based biology labs in the

MINIONE- INTRODUCED IN 2014, MINIONE® SYSTEMS IS A BRAND OF EDUCATIONAL LIFE SCIENCE PRODUCTS DEVELOPED BY THE COMPANY EMBI TEC®, WHICH HAS FOR YEARS MANUFACTURED BIOTECH EQUIPMENT AND REAGENTS USED BY TOP RESEARCH FACILITIES ALL OVER THE WORLD Read More »

AMACATHERA-DEVELOPING AND DELIVERING DRUGS FOR CHALLENGING THERAPEUTIC TARGETS

AMACATHERA-DEVELOPING AND DELIVERING DRUGS FOR CHALLENGING THERAPEUTIC TARGETS

Known for its diverse population and iconic skyline, Toronto is also the birthplace of the electron microscope, insulin, and pacemakers. And on a quiet side street south of the University of Toronto, one growing biotechnology company aims to contribute to the city’s entrepreneurial legacy.  AmacaThera is a clinical-stage biotechnology company developing a novel injectable material

AMACATHERA-DEVELOPING AND DELIVERING DRUGS FOR CHALLENGING THERAPEUTIC TARGETS Read More »

ANTIBE THERAPEUTICS -THIS TORONTO BIOTECH FIRM IS DEVELOPING SAFER TREATMENTS FOR PAIN AND INFLAMMATION.

ANTIBE THERAPEUTICS -THIS TORONTO BIOTECH FIRM IS DEVELOPING SAFER TREATMENTS FOR PAIN AND INFLAMMATION.

The key to innovation is seeing opportunity in unlikely places. For Antibe Therapeutics, the place is a cloud of noxious gas; the prize is a new generation of painkillers. In the wake of the opioid crisis, there is an urgent need for safer analgesics. Almost one-in-10 Canadians prescribed opioid medications report problematic use. Meanwhile, non-addictive

ANTIBE THERAPEUTICS -THIS TORONTO BIOTECH FIRM IS DEVELOPING SAFER TREATMENTS FOR PAIN AND INFLAMMATION. Read More »

OPEN BIONICS-MEET THE HERO ARM

OPEN BIONICS-MEET THE HERO ARM

Open Bionics is a Bristol-based robotics company working with global partners like Disney, Konami, Fox, and Eidos-Montréal to turn disabilities into superpowers. Founded by Samantha Payne MBE and Joel Gibbard MBE in 2014, the company has won over 30 engineering and innovation awards including two British Engineering Excellence awards and the global Robotics For Good

OPEN BIONICS-MEET THE HERO ARM Read More »

eXmoor-We Are eXmoor. We Are A Leading Technical and Strategic Consultancy Specialising In Cell And Gene Therapies

eXmoor-We Are eXmoor. We Are A Leading Technical and Strategic Consultancy Specialising In Cell And Gene Therapies

Cell and Gene therapies are a transformative new category of medicines, with the potential to treat, and even cure many complex, rare, life-limiting, or previously untreatable diseases. Cell and gene therapies are different to “traditional” medicines, and as such have unique manufacturing needs. Many cell therapies for example can involve extracting cells from a patient

eXmoor-We Are eXmoor. We Are A Leading Technical and Strategic Consultancy Specialising In Cell And Gene Therapies Read More »